The Road Ahead for Biden’s FDA Nominee Robert Califf

Stacy Cline Amin spoke to Axios about former Food and Drug Administration chief Robert Califf returning to his role.

Califf will face a Senate Health, Education, Labor, and Pensions Committee hearing on his nomination soon, though Stacy said he’s unlikely to get a floor vote by the end of the year, adding that the committee may not feel as much time pressure because [Woodcock] is “doing a good job and is generally well-liked.”

“This time has been really really hard for the agency,” Stacy said. “The staff is working around the clock. They are exhausted. I think it’s good they chose a nominee who has experience with the agency. It will be a smooth transition, likely. I think that’s important for the workforce there.”

Read the full article.